The medical-device sector agrees that an industry tax is necessary to help pay for a health care overhaul, but hopes the final fees will be lower than the Senate's proposed $40 billion tax, said Michael Mussallem, CEO of Edwards Lifesciences. "We're not huge fans of it, but I think at this point we very much believe that this is something that we need to do that's our contribution to health care reform to help pay for this big bill," Mussallem said at the Reuters Health Summit.

Full Story:

Related Summaries